Darlington hospital drops in to help support the air ambulance - raising £10k
Woodlands Hospital, in Darlington, chose the air ambulance as its charity of the year for 2024 and raised £10,720 with a range of activities, including sponsorship of the charity ball, and Easter and Christmas fundraising extravaganzas.
The cheque was handed over to the life-saving charity during a celebration day for its commercial partners.
Woodlands, part of Circle Health Group, is now one of GNAA's commercial partners, with the hospital's logo displayed on the back of a critical care response vehicle for a year.
(Image: Woodlands Hospital) The hospital's long-serving Executive Director, Debbie Dobbs, said: 'The Great North Air Ambulance carries out priceless work in our region and, as a hospital embedded in the local community, it is a charity which aligns with our own values.
(Image: Woodlands Hospital)Recommended reading:
Darlington dad praises building society for support of childhood cancer research
First look at £13m County Durham housing development creating 30 jobs
Concerns over Darlington's child poverty "shame" affecting hundreds of families
'Our staff really embraced the charity and we are all thrilled to have broken the £10,000 mark for such a great cause.'
During the celebration day, supporters were thanked by Dean Abbott, whose life was saved by the air ambulance after a motorcycle accident in August 2010.
The hospital staff have chosen St Teresa's Hospice as their charity for 2025.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
World-first IVF trial reduces risk of babies inheriting diseases
Eight healthy babies have been born in the UK using a new IVF technique that successfully reduced their risk of inheriting genetic diseases from their mothers, the results of a world-first trial said Wednesday. The findings were hailed as a breakthrough which raises hopes that women with mutations in their mitochondrial DNA could one day have children without passing debilitating or deadly diseases on to the children. One out of every 5,000 births is affected by mitochondrial diseases, which cannot be treated, and include symptoms such as impaired vision, diabetes and muscle wasting. In 2015, Britain became the first country to approve an in-vitro fertilisation (IVF) technique that uses a small amount of healthy mitochondrial DNA from the egg of a donor -- along with the mother's egg and father's sperm. Some have called the result of this process "three-parent babies", though researchers have pushed back at this term because only roughly 0.1 percent of the newborn's DNA comes from the donor. The results of the much-awaited UK trial were published in several papers in the New England Journal of Medicine. - 'Important reproductive option' - Out of 22 women to undergo the treatment at the Newcastle Fertility Centre in northeast England, eight babies were born. The four boys and four girls now range from under six months to over two years old. The amount of mutated mitochondrial DNA -- which causes disease -- was reduced by 95-100 percent in six of the babies, according to the research. For the other two newborns, the amount fell by 77-88 percent, which is below the range that causes disease. This indicates the technique was "effective in reducing transmission" of diseases between mother and child, one of the studies said. The eight children are currently healthy, though one had a disturbance of their heart's rhythm which was successfully treated, the researchers said. Their health will be followed up over the coming years to see if problems arise. Nils-Goran Larsson, a Swedish reproductive expert not involved in the research, hailed the "breakthrough". The new technique offers a "very important reproductive option" for families affected by "devastating" mitochondrial diseases, he added. - Ethical review - Mitochondrial donation remains controversial and has not been approved in many countries, including the United States and France. Religious leaders have opposed the procedure because it involves the destruction of human embryos. Other opponents have expressed fears it could pave the way for genetically engineered "designer babies". An ethical review carried out by the UK's independent Nuffield Council on Bioethics was "instrumental" in conducting the new research, the council's director Danielle Hamm said Wednesday. Peter Thompson, head of the UK's Human Fertilisation and Embryology Authority which approved the procedure, said only people with a "very high risk" of passing on a mitochondrial disease would be eligible for the treatment. Ethical concerns have also been raised over the use of mitochondrial donation for infertility in Greece and Ukraine. French mitochondrial disease specialist Julie Stefann told AFP that "it is a question of the risk-benefit ratio: for a mitochondrial disease, the benefit is obvious". "In the context of infertility, it has not been proven," she added. Oxford University reproductive genetics expert Dagan Wells observed that "some scientists will be a little disappointed that so much time and effort has, so far, only led to the birth of eight children". Among the children being closely monitored are three that showed some signs of what is known as "reversal", which is still little understood. It is "a phenomenon where the therapy initially succeeds in producing an embryo with very few defective mitochondria, but by the time the child is born the proportion of abnormal mitochondria in its cells has significantly increased," he explained. dl/gv
Yahoo
an hour ago
- Yahoo
Scientists unlock secret behind rare disease where flu can cause paralysis
The family of a man who was paralysed at the age of two after catching the flu have expressed their 'hope' as scientists have discovered that a faulty gene may be responsible for the rare condition. It is hoped that the finding could potentially one day lead to a treatment for the illness. When Timothy Bingham was two, he had a mild flu-like illness which left him unable to walk. Three years later following another infection, he was paralysed and has been in a wheelchair ever since. Kate Bingham, mother of Timothy, who is now 28, said: 'About 25 years ago Tim got a flu like infection and a temperature. 'What seemed like a minor illness had devastating consequences. 'The attack, and subsequent attacks – did terrible damage. First to his legs, then his arms, his face and his chest. 'And now he needs 24-hour care. His diaphragm barely works at all so he can't cough. 'It's hard for him to chew and he can't drink unassisted. He can't move in bed so needs turning throughout the night. The things we all take for granted he can't do.' The rare condition was spotted again in 2011 when an unnamed eight-month-old girl was left unable to breathe on her own without the support of a ventilator after a mild chest infection. Scientists suspected that there could be a genetic reason behind the condition after the girl's two brothers had experienced similar severe problems following mild infections. Now scientists at the University of Manchester have found a genetic mechanism behind the severe reactions to mild infections seen among these children – a change to a gene called RCC1. Researchers found that 24 children from 12 families from the UK, Turkey, the Czech Republic, Germany, Iran, India, Saudi Arabia, Cyprus, and Slovakia have been found to have changes in the same gene. Writing in the journal Lancet Neurology, the research team describe how the condition 'mimics' Guillain-Barre syndrome – a rare condition in which a person's immune system attacks the nerves – and 'overlaps mechanistically' with motor neurone disease. The research team, led by Professor Bill Newman from the University of Manchester, said that their study reveals that 'variants in RCC1 as a novel cause of neurological disease.' 'Until this study, little was known about why some people experience severe nerve damage after they have had a mild infection like flu or a stomach upset,' Professor Newman said. 'This work provides families with an explanation and is the first step in us developing an effective treatment. As children are well before they develop nerve damage following an infection, this gives us an opportunity to treat at risk children before problems occur. 'The similarity with Guillain-Barre syndrome and with conditions like motor neuron disease may help us understand these more common conditions and why some people are at greater risk and what treatments may be effective.' Mrs Bingham from Cheltenham, Gloucestershire, said: 'As Tim's mum the discovery of a gene which is linked to what happened to Tim means everything to me. 'For so long we have lived with uncertainty of not knowing the full picture. 'This breakthrough brings us great hope as it will do to all those people who have waited years for answers. This is something that helps us look to the future.' She added: 'I'm proud of how strong Tim has been. 'He now has a girlfriend he met online who is wonderful. 'He proves there is life beyond disability.' The study was funded by the National Institute for Health and Care Research, LifeArc and the Wellcome Trust. Sam Barrell, chief executive of LifeArc, said, 'For many people living with rare conditions, the wait for a diagnosis can be agonisingly long – around a third wait more than five years. 'In Timothy's case, that uncertainty stretched for over twenty years. 'This discovery provides a potential target for treatment and the first step towards delivering a brighter future for people that could be living with this same devastating condition.'
Yahoo
an hour ago
- Yahoo
Routine eye scan could predict 10-year heart attack and stroke risk
A scan which forms part of a routine eye test could help predict a person's risk of having a heart attack or stroke within the next 10 years, a study suggests. Researchers used artificial intelligence (AI) to analyse digital retinal photographs, which are taken to capture images from the back of the eye to look for certain conditions. The technology was able to produce personalised risk predictors in less than a second. It is hoped the simple test could one day be offered alongside blood pressure and cholesterol checks to allow doctors to treat patients earlier. For the study, published in the journal Cardiovascular Diabetology, researchers at the University of Dundee trialled the AI software on the eye scans of people with type 2 diabetes. Those with the condition have routine eye tests to check for diabetic retinopathy, a condition where high blood sugar levels damage the blood sugar in the retina. Dr Ify Mordi, British Heart Foundation research fellow at the University of Dundee and consultant cardiologist, said: 'It may be surprising, but the eyes are a window to the heart. 'If there is damage or narrowing of the blood vessels at the back of the eye, there is a good chance that will also be seen in the blood vessels further inside the body, supplying the heart, which could lead to a heart attack or stroke.' Experts instructed the technology to initially look for warning signs on the images, such as blood vessel narrowing or blockages. It was then permitted to look for any detail in the photographs, such as the size or arrangement of blood vessels, before being trained using 4,200 images. The AI tool was able to predict the people who would go on to have 'major cardiovascular events', like heart attacks or strokes, within a decade with 70% accuracy. Dr Mordi added: 'This is a one-stop scan which is routinely performed and takes less than a minute. 'It could be an important part of the package, alongside blood pressure and cholesterol checks, in identifying people who could benefit from medication or lifestyle changes.' Professor Bryan Williams, chief scientific and medical officer at the British Heart Foundation, said: 'The more accurately we can detect someone's risk of a heart attack or stroke, the better the opportunities to prevent these happening. 'Cutting-edge innovations, like the use of retinal scans alongside health checks, could play a role in improving risk prediction, which is important if we are to reach the British Heart Foundation's goal to prevent 125,000 heart attacks and strokes in the UK by 2035. 'However, more research is needed to show this prediction accuracy is robust, and to determine the feasibility of incorporating retinal scans into clinical practice.' Reacting to the study, Dr Clare Jonas, research lead at the Stroke Association, said: 'AI analyses of health data, gathered through screening technology such as this eye scan, have exciting potential for better early detection, especially for those with diabetes who have a greater chance of having a stroke. 'Advances like these could make it easier for people at risk of stroke to take the right steps to stop it from happening. 'Whilst there are still many practical questions to answer about whether, when and how AI could be used in clinical practice, we hope the Government's 10 Year Health Plan will take such technological advances into account to stop more strokes from devastating people's lives.' Sign in to access your portfolio
